Fibrogen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fibrogen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fibrogen Today - Breaking & Trending Today

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Meichiel Keenandirector , Rahul Aggarwal , David Delucia , Deyaa Adib , Corporate Communications , Fibrogen Inc , Exchange Commission , Drug Administration , American Society For Clinical Oncology , China Health Authority , Fortis Therapeutics Sponsored Phase , Chief Medical Officer , California San Francisco , Lead Investigator , American Society , Clinical Oncology , Fortis Therapeutics , Supplemental New Drug Application , China Health , Looking Statements This , Annual Report , Investor Relations ,

US$1.25: That's What Analysts Think FibroGen, Inc. (NASDAQ:FGEN) Is Worth After Its Latest Results

As you might know, FibroGen, Inc. ( NASDAQ:FGEN ) last week released its latest full-year, and things did not turn out. ....

Revenue Estimates , Arnings Per Share , Price Target , Price Targets ,

Analysts Set FibroGen, Inc. (NASDAQ:FGEN) Target Price at $18.75

Shares of FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) have earned an average recommendation of “Reduce” from the six analysts that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell rating and four have issued a hold rating on the company. The average 1-year price objective among brokerages […] ....

Schroder Investment Management Group , Fibrogen Inc , Jacobs Levy Equity Management Inc , Armistice Capital , Hermes Inc , Fibrogen Company Profile , Acadian Asset Management , Get Free Report , Investment Management Group , Asset Management , Levy Equity Management , Federated Hermes , Get Free , Fibrogen Daily , Nasdaq Fgen ,

Brokerages Set FibroGen, Inc. (NASDAQ:FGEN) Price Target at $18.75

FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) has received a consensus recommendation of “Reduce” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation and four have issued a hold recommendation on the company. The average 12 month price […] ....

Voya Investment Management , Pricet Rowe Associates Inc , Fibrogen Company Profile , Barclays Plc , Fibrogen Inc , Get Free Report , Marketbeat Ratings , Investment Management , Pennant Investors , Get Free , Fibrogen Daily , Nasdaq Fgen ,

FibroGen, Inc. (FGEN) Stock Price | Stock Quote Nasdaq

FibroGen, Inc. (FGEN.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock FibroGen, Inc. | Nasdaq: FGEN | Nasdaq ....

Fibrogen Inc , Nc Quotes , Tock Quote ,